{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:03Z","timestamp":1792782663092,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Jiangxi Province","award":["20242BAB25467"],"award-info":[{"award-number":["20242BAB25467"]}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202410237"],"award-info":[{"award-number":["202410237"]}],"id":[{"id":"https:\/\/ror.org\/03vc7fb96","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04413-z","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:15:36Z","timestamp":1782972936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGB1 ubiquitination inhibition and extracellular secretion, mediated by m6A modified-exosomal lncRNA MALAT1, creates a communication between NK92-MI cells and tumor cells to aggravate acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"75","author":[{"given":"Xiaofang","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"4413_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/bph.16029","volume":"180","author":"Z Chen","year":"2023","unstructured":"Chen Z, Xin Q, Wei W et al (2023) The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia. Br J Pharmacol 180:1017\u20131037","journal-title":"Br J Pharmacol"},{"key":"4413_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet 395:1146\u20131162","journal-title":"Lancet"},{"key":"4413_CR3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1200\/GO.21.00049","volume":"7","author":"SL Chen","year":"2021","unstructured":"Chen SL, Zhang H, Gale RP et al (2021) Toward the cure of acute lymphoblastic leukemia in children in China. JCO Glob Oncol 7:1176\u20131186","journal-title":"JCO Glob Oncol"},{"key":"4413_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12935-024-03255-y","volume":"24","author":"P Sharma","year":"2024","unstructured":"Sharma P, Kaur P, Bhatia P et al (2024) Novel lncRNAs LINC01221, RP11-472G21.2 and CRNDE are markers of differential expression in pediatric patients with T cell acute lymphoblastic leukemia. Cancer Cell Int 24:65","journal-title":"Cancer Cell Int"},{"key":"4413_CR5","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1080\/21655979.2022.2031405","volume":"13","author":"JK Ju","year":"2022","unstructured":"Ju JK, Han WN, Shi CL (2022) Long non-coding RNA (lncRNA) plasmacytoma variant translocation 1 gene (PVT1) modulates the proliferation and apoptosis of acute lymphoblastic leukemia cells by sponging miR-486-5p. Bioengineered 13:4587\u20134597","journal-title":"Bioengineered"},{"key":"4413_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236064","author":"M Xagorari","year":"2021","unstructured":"Xagorari M, Marmarinos A, Kossiva L et al (2021) Overexpression of the GR riborepressor LncRNA GAS5 results in poor treatment response and early relapse in childhood B-ALL. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13236064","journal-title":"Cancers (Basel)"},{"key":"4413_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010234","author":"MA Hussein","year":"2024","unstructured":"Hussein MA, Valinezhad K, Adel E et al (2024) MALAT-1 is a key regulator of epithelial-mesenchymal transition in cancer: a potential therapeutic target for metastasis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16010234","journal-title":"Cancers (Basel)"},{"key":"4413_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/pin.12993","volume":"70","author":"Y Song","year":"2020","unstructured":"Song Y, Guo NH, Zheng JF (2020) LncRNA-MALAT1 regulates proliferation and apoptosis of acute lymphoblastic leukemia cells via miR-205-PTK7 pathway. Pathol Int 70:724\u2013732","journal-title":"Pathol Int"},{"key":"4413_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/mec.17545","author":"EP Ahi","year":"2024","unstructured":"Ahi EP, Singh P (2024) Emerging orchestrator of ecological adaptation: m(6)A regulation of post-transcriptional mechanisms. Mol Ecol. https:\/\/doi.org\/10.1111\/mec.17545","journal-title":"Mol Ecol"},{"key":"4413_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12887-024-05053-x","volume":"24","author":"KY Qiu","year":"2024","unstructured":"Qiu KY, Liao XY, Fang JP et al (2024) TARGET based m(6)A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia. BMC Pediatr 24:574","journal-title":"BMC Pediatr"},{"key":"4413_CR11","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.2147\/CMAR.S335925","volume":"13","author":"A Luo","year":"2021","unstructured":"Luo A, Yang L, Li M et al (2021) Genetic variants in METTL14 are associated with the risk of acute lymphoblastic leukemia in southern Chinese children: a five-center case-control study. Cancer Manag Res 13:9189\u20139200","journal-title":"Cancer Manag Res"},{"key":"4413_CR12","doi-asserted-by":"publisher","first-page":"106653","DOI":"10.1016\/j.leukres.2021.106653","volume":"110","author":"L An","year":"2021","unstructured":"An L, Li X, Yang J (2021) MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12. Leuk Res 110:106653","journal-title":"Leuk Res"},{"key":"4413_CR13","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1111\/odi.14220","volume":"29","author":"J Li","year":"2023","unstructured":"Li J, Momen-Heravi F, Wu X et al (2023) Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Dis 29:2012\u20132026","journal-title":"Oral Dis"},{"key":"4413_CR14","doi-asserted-by":"publisher","first-page":"1384109","DOI":"10.3389\/fonc.2024.1384109","volume":"14","author":"G Lv","year":"2024","unstructured":"Lv G, Yang M, Gai K et al (2024) Multiple functions of HMGB1 in cancer. Front Oncol 14:1384109","journal-title":"Front Oncol"},{"key":"4413_CR15","first-page":"368","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Xie J, Li X et al (2020) Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia cells. Oncol Lett 19:368\u2013378","journal-title":"Oncol Lett"},{"key":"4413_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.omtn.2021.12.024","volume":"27","author":"D Shen","year":"2022","unstructured":"Shen D, Ding L, Lu Z et al (2022) METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Mol Ther Nucleic Acids 27:547\u2013561","journal-title":"Mol Ther Nucleic Acids"},{"key":"4413_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910257","author":"M Juszczak","year":"2024","unstructured":"Juszczak M, Tokarz P, Wozniak K (2024) Potential of NRF2 inhibitors-Retinoic Acid, K67, and ML-385-in overcoming Doxorubicin resistance in promyelocytic leukemia cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251910257","journal-title":"Int J Mol Sci"},{"key":"4413_CR18","doi-asserted-by":"publisher","first-page":"681250","DOI":"10.3389\/fonc.2021.681250","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Li H, Wang L et al (2021) Transcriptomic analyses reveal B-Cell Translocation Gene 2 as a potential therapeutic target in ovarian cancer. Front Oncol 11:681250","journal-title":"Front Oncol"},{"key":"4413_CR19","doi-asserted-by":"publisher","first-page":"7053521","DOI":"10.1155\/2022\/7053521","volume":"2022","author":"SS Sahraei","year":"2022","unstructured":"Sahraei SS, Davoodi Asl F, Kalhor N et al (2022) A comparative study of gene expression in menstrual blood-derived stromal cells between endometriosis and healthy women. Biomed Res Int 2022:7053521","journal-title":"Biomed Res Int"},{"key":"4413_CR20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","volume":"11","author":"M Duan","year":"2024","unstructured":"Duan M, Liu H, Xu S et al (2024) IGF2BPs as novel m(6)A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment. Genes Dis 11:890\u2013920","journal-title":"Genes Dis"},{"key":"4413_CR21","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1210\/clinem\/dgad725","volume":"109","author":"G Li","year":"2024","unstructured":"Li G, Chen W, Jiang K et al (2024) Exosome-mediated delivery of miR-519e-5p promotes malignant tumor phenotype and CD8+ T-cell exhaustion in metastatic PTC. J Clin Endocrinol Metab 109:1601\u20131617","journal-title":"J Clin Endocrinol Metab"},{"key":"4413_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12915-022-01277-4","volume":"20","author":"T O'Grady","year":"2022","unstructured":"O\u2019Grady T, Njock MS, Lion M et al (2022) Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels. BMC Biol 20:72","journal-title":"BMC Biol"},{"issue":"13","key":"4413_CR23","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.3390\/ijms25137500","volume":"25","author":"J Gallardo-Zapata","year":"2024","unstructured":"Gallardo-Zapata J, P\u00e9rez-Figueroa E, Olivar-L\u00f3pez V, Medina-Sans\u00f3n A, Jim\u00e9nez-Hern\u00e1ndez E, Ortega E, Maldonado-Bernal C (2024) TLR agonists modify NK cell activation and increase its cytotoxicity in acute lymphoblastic leukemia. Int J Mol Sci 25(13):7500","journal-title":"Int J Mol Sci"},{"key":"4413_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ijc.11555","volume":"108","author":"RS Treichel","year":"2004","unstructured":"Treichel RS, Bunuan M, Hahn N et al (2004) Altered conjugate formation and altered apoptosis of multidrug-resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cells. Int J Cancer 108:78\u201385","journal-title":"Int J Cancer"},{"key":"4413_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/CM9.0000000000003090","volume":"137","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qin Y, Wu Y et al (2024) Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications. Chin Med J (Engl) 137:1151\u20131159","journal-title":"Chin Med J (Engl)"},{"key":"4413_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2019.01.003","volume":"692","author":"S Pouyanrad","year":"2019","unstructured":"Pouyanrad S, Rahgozar S, Ghodousi ES (2019) Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. Gene 692:35\u201343","journal-title":"Gene"},{"key":"4413_CR27","doi-asserted-by":"publisher","first-page":"e70039","DOI":"10.1002\/ctm2.70039","volume":"14","author":"X Shi","year":"2024","unstructured":"Shi X, Zhang X, Huang X et al (2024) N(6)-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1. Clin Transl Med 14:e70039","journal-title":"Clin Transl Med"},{"key":"4413_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR (2018) Reading m(6)A in the transcriptome: m(6)A-binding proteins. Trends Cell Biol 28:113\u2013127","journal-title":"Trends Cell Biol"},{"key":"4413_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41419-025-07624-x","volume":"16","author":"H Luo","year":"2025","unstructured":"Luo H, Liu L, Liu X et al (2025) Interleukin-33 (IL-33) promotes DNA damage-resistance in lung cancer. Cell Death Dis 16:274","journal-title":"Cell Death Dis"},{"key":"4413_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41416-025-02989-4","volume":"132","author":"D Andel","year":"2025","unstructured":"Andel D, Nouwens AJ, Klaassen S et al (2025) Rational design of alternative treatment options for radioresistant rectal cancer using patient-derived organoids. Br J Cancer 132:973\u2013981","journal-title":"Br J Cancer"},{"key":"4413_CR31","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1248\/bpb.b25-00420","volume":"48","author":"Y Mizoguchi","year":"2025","unstructured":"Mizoguchi Y, Mori N, Kitabatake K et al (2025) P2Y12 receptor antagonists decrease the radiation resistance of B16 melanoma by suppressing DNA repair. Biol Pharm Bull 48:1775\u20131783","journal-title":"Biol Pharm Bull"},{"key":"4413_CR32","doi-asserted-by":"publisher","first-page":"217736","DOI":"10.1016\/j.canlet.2025.217736","volume":"625","author":"H Luo","year":"2025","unstructured":"Luo H, Huang MF, Xu A et al (2025) Mutant p53 confers chemoresistance by activating KMT5B-mediated DNA repair pathway in nasopharyngeal carcinoma. Cancer Lett 625:217736","journal-title":"Cancer Lett"},{"key":"4413_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","volume":"21","author":"M Simons","year":"2009","unstructured":"Simons M, Raposo G (2009) Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol 21:575\u2013581","journal-title":"Curr Opin Cell Biol"},{"key":"4413_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-021-01492-7","volume":"21","author":"R Hosseini","year":"2022","unstructured":"Hosseini R, Sarvnaz H, Arabpour M et al (2022) Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer 21:15","journal-title":"Mol Cancer"},{"key":"4413_CR35","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1007\/s10620-024-08536-0","volume":"69","author":"CW Tang","year":"2024","unstructured":"Tang CW, Yang JH, Qin JW et al (2024) Regulation of the PD-1\/PD-L1 axis and NK cell dysfunction by exosomal miR-552-5p in gastric cancer. Dig Dis Sci 69:3276\u20133289","journal-title":"Dig Dis Sci"},{"key":"4413_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","volume":"22","author":"QM Wang","year":"2024","unstructured":"Wang QM, Lian GY, Sheng SM et al (2024) Exosomal lncRNA NEAT1 inhibits NK-cell activity to promote multiple myeloma cell immune escape via an EZH2\/PBX1 axis. Mol Cancer Res 22:125\u2013136","journal-title":"Mol Cancer Res"},{"key":"4413_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00367-20","author":"X Zhou","year":"2020","unstructured":"Zhou X, Wang L, Zou W et al (2020) hnRNPA2B1 associated with recruitment of RNA into exosomes plays a key role in Herpes Simplex Virus 1 release from infected cells. J Virol. https:\/\/doi.org\/10.1128\/JVI.00367-20","journal-title":"J Virol"},{"key":"4413_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI130892","volume":"130","author":"C Chen","year":"2020","unstructured":"Chen C, Luo Y, He W et al (2020) Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest 130:404\u2013421","journal-title":"J Clin Invest"},{"key":"4413_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191\u2013195","journal-title":"Nature"},{"key":"4413_CR40","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","volume":"13","author":"JE Ellerman","year":"2007","unstructured":"Ellerman JE, Brown CK, de Vera M et al (2007) Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13:2836\u20132848","journal-title":"Clin Cancer Res"},{"key":"4413_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1052353","volume":"4","author":"M Parodi","year":"2015","unstructured":"Parodi M, Pedrazzi M, Cantoni C et al (2015) Natural killer (NK)\/melanoma cell interaction induces NK-mediated release of chemotactic high mobility group box-1 (HMGB1) capable of amplifying NK cell recruitment. Oncoimmunology 4:e1052353","journal-title":"Oncoimmunology"},{"key":"4413_CR42","first-page":"445","volume":"33","author":"M Dahlhaus","year":"2013","unstructured":"Dahlhaus M, Schult C, Lange S et al (2013) MicroRNA 181a influences the expression of HMGB1 and CD4 in acute leukemias. Anticancer Res 33:445\u2013452","journal-title":"Anticancer Res"},{"key":"4413_CR43","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41467-020-16553-6","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Yuan J, Chen F et al (2020) Long noncoding RNA SAM promotes myoblast proliferation through stabilizing Sugt1 and facilitating kinetochore assembly. Nat Commun 11:2725","journal-title":"Nat Commun"},{"key":"4413_CR44","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.7150\/thno.64880","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Luo W, Huang L et al (2021) A novel lncRNA linc-AhRA negatively regulates innate antiviral response in murine microglia upon neurotropic herpesvirus infection. Theranostics 11:9623\u20139651","journal-title":"Theranostics"},{"key":"4413_CR45","doi-asserted-by":"publisher","first-page":"1004429","DOI":"10.3389\/fcell.2022.1004429","volume":"10","author":"C Yu","year":"2022","unstructured":"Yu C, Rao D, Wang T et al (2022) Emerging roles of TRIM27 in cancer and other human diseases. Front Cell Dev Biol 10:1004429","journal-title":"Front Cell Dev Biol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04413-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:29Z","timestamp":1790164949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04413-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04413-z","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving clinical samples was approved by the Ethics Committee of The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, and performed in accordance with the Declaration of Helsinki. Written informed consent was collected from all participators before our experiment.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the Ethic Committee of The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University. They were performed in accordance with the ARRIVE guidelines.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"232"}}